bioAffinity Technologies, Inc. BIAF

Full chart Compare
Set alert

Price alert · BIAF

All alert types
3.17 USD -0.02 (-0.66%)

Nov 4, 2026, 3:03 PM EST

2.95 Day range 3.22
2.66 52-week range 80.70
YTD
-82.10%
1 year
-89.89%

Revenue & Expenses

Revenue → Gross Profit: $1.43MGross Profit → Expenses: $1.43MRevenue → Cost of Revenue: $4.73MExpenses → Selling, General & Admin: $9.91MExpenses → Research & Development: $2.09MExpenses → Interest Expense: $44.37KExpenses → Other Expenses: $4.25MExpenses → Income Tax: $44.04KNet Loss → Expenses: $14.91MGross Profit$1.43MNet Loss$14.91MCost of Revenue$4.73MExpenses$16.34MSelling, General & Admin$9.91MResearch & Development$2.09MInterest Expense$44.37KOther Expenses$4.25MIncome Tax$44.04KRevenue$6.16M

Latest period ending Dec 31, 2025 · select a line to chart its full history

BIAF annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
6.16M9.36M2.53M4.80K0
1.94M3.38M791.62K4.34K0
-10.57M-8.95M-7.97M-4.01M-2.21M
-14.91M-9.04M-7.94M-8.15M-6.33M
-130.00-337.00-410.00-815.00-1,062.00
BIAF annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
6.45M1.11M2.82M11.41M1.36M
10.96M6.51M8.22M12.18M1.45M
3.68M3.91M3.37M1.14M13.20M
1.16M1.50M1.58M251.75K11.36M
7.28M2.60M4.86M11.04M-15.79M
BIAF annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-9.33M-7.26M-6.04M-4.07M-2.05M
-60.57K-79.08K-2.21M-219.99K0
14.73M5.63M-344.98K14.34M3.33M
-60.57K-79.08K-22.90K-219.99K0
5.34M-1.72M-8.59M10.05M1.28M